Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Pediatr Infect Dis J. 2018 Jan;37(1):43–51. doi: 10.1097/INF.0000000000001687

Fig. 2.

Fig. 2

Proportion of children with plasma Cmax of isoniazid (INH) < 3 μg/mL, rifampin (RIF) < 8 μg/mL and pyrazinamide (PZA) < 20 μg/mL, PZA < 35 μg/mL and ethambutol (EMB) < 2 μg/mL.